FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Krishna Chatterjee

Research Profile

Chemicals & Drugs

Disorders

Physiology

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Living Beings

Mouse

Co-author Network

Publications

TOP 3
V Krishna K Chatterjee
Thyroid in 2012: Advances in thyroid development, hormone action and neoplasia.
Marianne Øksnes; Gesine Meyer; Lucyna Papierska; Anna Parolo; Klaus Badenhoop; Sophie Bensing; Corrado Betterle; V Krishna K Chatterjee; Alberto Falorni; Roberta Giordano; Annika Hackemann; Anna-Lena Hulting; Eystein S Husebye; Wojciech Jeske; Kämpe Olle; Anna A Kasperlik-Zaluska; Kristian Løvås
Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL.
Mark Gurnell; David J Halsall; V Krishna K Chatterjee
What should be done when thyroid function tests do not make sense?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Krishna Chatterjee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: V Krishna K Chatterjee
Thyroid in 2012: Advances in thyroid development, hormone action and neoplasia.
Nature reviews. Endocrinology 2013;9(2):74-6.
2012: Marianne Øksnes; Gesine Meyer; Lucyna Papierska; Anna Parolo; Klaus Badenhoop; Sophie Bensing; Corrado Betterle; V Krishna K Chatterjee; Alberto Falorni; Roberta Giordano; Annika Hackemann; Anna-Lena Hulting; Eystein S Husebye; Wojciech Jeske; Kämpe Olle; Anna A Kasperlik-Zaluska; Kristian Løvås
Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL.
The Journal of clinical endocrinology and metabolism 2012;97(2):568-76.
2011: Mark Gurnell; David J Halsall; V Krishna K Chatterjee
What should be done when thyroid function tests do not make sense?
Clinical endocrinology 2011;74(6):673-8.
2010: Mireille Castanet; Uma Mallya; Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Stephanie Demuth; F Lucy Raymond; John Schwabe; Mark Gurnell; V Krishna K Chatterjee
Maternal isodisomy for chromosome 9 causing homozygosity for a novel FOXE1 mutation in syndromic congenital hypothyroidism.
The Journal of clinical endocrinology and metabolism 2010;95(8):4031-6.
2010: Kristian Løvås; Suzanne Curran; Marianne Oksnes; Eystein S Husebye; Felicia A Huppert; V Krishna K Chatterjee
Development of a disease-specific quality of life questionnaire in Addison's disease.
The Journal of clinical endocrinology and metabolism 2010;95(2):545-51.
2009: Oscar Rubio Cabezas; Vishwajeet Puri; Incoronata Murano; Vladimir Saudek; Robert K Semple; Satya Dash; Caroline S S Hyden; William Bottomley; Corinne Vigouroux; Jocelyne Magré; Philippa Raymond-Barker; Peter R Murgatroyd; Anil Chawla; Jeremy N Skepper; V Krishna K Chatterjee; Sara Suliman; Ann-Marie Patch; Anil K Agarwal; Abhimanyu Garg; Inês Barroso; Saverio Cinti; Michael P Czech; Jesús Argente; Stephen O'Rahilly; David B Savage
Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC.
EMBO molecular medicine 2009;1(5):280-7.
2009: Kristian Løvås; Clara G Gjesdal; Monika Christensen; Anette B Wolff; Bjørg Almås; Johan Svartberg; Kristian J Fougner; Unni Syversen; Jens Bollerslev; Jan A Falch; Penelope J Hunt; V Krishna K Chatterjee; Eystein S Husebye
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
European journal of endocrinology / European Federation of Endocrine Societies 2009;160(6):993-1002.
2009: P J D Owen; V Krishna K Chatterjee; Rhys John; D Halsall; John H Lazarus
Augmentation index in resistance to thyroid hormone (RTH).
Clinical endocrinology 2009;70(4):650-4.
2009: Kristian Løvås; Ian McFarlane; Huy-Hoang Nguyen; Suzanne Curran; John W R Schwabe; Halsall David; Rita Bernhardt; A Michael Wallace; V Krishna K Chatterjee
A novel CYP11B2 gene mutation in an Asian family with aldosterone synthase deficiency.
The Journal of clinical endocrinology and metabolism 2009;94(3):914-9.
2008: Elli M Gurnell; Penelope J Hunt; Suzanne E Curran; Catherine L Conway; Eleanor M Pullenayegum; Felicia A Huppert; Juliet E Compston; Joe Herbert; V Krishna K Chatterjee
Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial.
The Journal of clinical endocrinology and metabolism 2008;93(2):400-9.
2007: David B Savage; Robert K Semple; V Krishna K Chatterjee; J K H Wales; R J M Ross; Stephen O'Rahilly
A clinical approach to severe insulin resistance.
Endocrine development 2007;11():122-32.
2006: Sarah L Gray; Edoardo Dalla Nora; Johannes Grosse; Monia Manieri; Tobias Stoeger; Gema Medina-Gomez; Keith Burling; Sigrid Wattler; Andreas Russ; Giles S H Yeo; V Krishna K Chatterjee; Stephen O'Rahilly; Peter J Voshol; Saverio Cinti; Antonio Vidal-Puig
Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice.
Diabetes 2006;55(10):2669-77.
2006: Halsall David; Michael N Fahie-Wilson; S Kate Hall; Peter Barker; Janet Anderson; Rousseau Gama; V Krishna K Chatterjee
Macro thyrotropin-IgG complex causes factitious increases in thyroid-stimulating hormone screening tests in a neonate and mother.
Clinical chemistry 2006;52(10):1968-9; author reply 1969-70.
2006: Ibrahim Baris; Ayse Engin Arisoy; A Smith; M Agostini; C S Mitchell; S M Park; A M Halefoglu; Emine Zengin; V Krishna K Chatterjee; Esra Battaloglu
A novel missense mutation in human TTF-2 (FKHL15) gene associated with congenital hypothyroidism but not athyreosis.
The Journal of clinical endocrinology and metabolism 2006;91(10):4183-7.
2006: Robert K Semple; Maria A Soos; Jian'an Luan; C S Mitchell; J C Wilson; Mark Gurnell; Elaine Cochran; Phillip Gorden; V Krishna K Chatterjee; Nicholas J Wareham; Stephen O'Rahilly
Elevated plasma adiponectin in humans with genetically defective insulin receptors.
The Journal of clinical endocrinology and metabolism 2006;91(8):3219-23.
2006: Robert K Semple; V Krishna K Chatterjee; Stephen O'Rahilly
PPAR gamma and human metabolic disease.
The Journal of clinical investigation 2006;116(3):581-9.
2005: Alasdair J Coles; Sara Thompson; Amanda L Cox; Suzanne Curran; Elli M Gurnell; V Krishna K Chatterjee
Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells.
European journal of immunology 2005;35(12):3694-703.
2005: S M Park; V Krishna K Chatterjee
Genetics of congenital hypothyroidism.
Journal of medical genetics 2005;42(5):379-89.
2005: Ulf Risérus; Garry D Tan; Barbara A Fielding; Matt J Neville; Jenny Currie; David B Savage; V Krishna K Chatterjee; Keith N Frayn; Stephen O'Rahilly; Fredrik Karpe
Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma.
Diabetes 2005;54(5):1379-84.
2005: Robert K Semple; Aline Meirhaeghe; Antonio Vidal-Puig; John W R Schwabe; David Wiggins; Geoffrey F Gibbons; Mark Gurnell; V Krishna K Chatterjee; Stephen O'Rahilly
A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms.
Endocrinology 2005;146(4):1871-82.
2005: David B Savage; Peter R Murgatroyd; V Krishna K Chatterjee; Stephen O'Rahilly
Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophy.
The Journal of clinical endocrinology and metabolism 2005;90(3):1446-52.
2004: Emily Verrier; Lijun Wang; Carol Wadham; Nathaniel Albanese; Chris Hahn; Jennifer R Gamble; V Krishna K Chatterjee; Mathew A Vadas; Pu Xia
PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase.
Circulation research 2004;94(11):1515-22.
2004: Maura Agostini; Mark Gurnell; David B Savage; Emily M Wood; Aaron G Smith; Odelia Rajanayagam; Keith T Garnes; Sidney H Levinson; H Eric Xu; John W R Schwabe; Timothy M Willson; Stephen O'Rahilly; V Krishna K Chatterjee
Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma.
Endocrinology 2004;145(4):1527-38.
2004: S-M Park; RJ Clifton-Bligh; P Betts; V Krishna K Chatterjee
Congenital hypothyroidism and apparent athyreosis with compound heterozygosity or compensated hypothyroidism with probable hemizygosity for inactivating mutations of the TSH receptor.
Clinical endocrinology 2004;60(2):220-7.
2004: Mark Gurnell; V Krishna K Chatterjee
Nuclear receptors in disease: thyroid receptor beta, peroxisome-proliferator-activated receptor gamma and orphan receptors.
Essays in biochemistry 2004;40():169-89.
2004: Elli M Gurnell; Sudheep K Thomas; Ian McFarlane; I Munday; Kottekkattu K Balan; Lawrence H Berman; V Krishna K Chatterjee; Gordon C Wishart
Focused parathyroid surgery with intraoperative parathyroid hormone measurement as a day-case procedure.
The British journal of surgery 2004;91(1):78-82.
2004: Paul W Franks; Jian'an Luan; P O Browne; Anne-Helen Harding; Stephen O'Rahilly; V Krishna K Chatterjee; Nicholas J Wareham
Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?
Metabolism: clinical and experimental 2004;53(1):11-6.
2003: Melwyn Sequeira; Farakid Al-Khafaji; SooMi Park; Mark D Lewis; Malcolm H Wheeler; V Krishna K Chatterjee; Bharat Jasani; Marian Ludgate
Production and application of polyclonal antibody to human thyroid transcription factor 2 reveals thyroid transcription factor 2 protein expression in adult thyroid and hair follicles and prepubertal testis.
Thyroid : official journal of the American Thyroid Association 2003;13(10):927-32.
2003: Mark Gurnell; David B Savage; V Krishna K Chatterjee; Stephen O'Rahilly
The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation.
The Journal of clinical endocrinology and metabolism 2003;88(6):2412-21.
2003: David B Savage; Garry D Tan; Carlo L Acerini; Susan A Jebb; Maura Agostini; Mark Gurnell; Rachel L Williams; A Margot Umpleby; E Louise Thomas; Jimmy D Bell; Adrian K Dixon; Fidelma Dunne; Romina Boiani; Saverio Cinti; Antonio Vidal-Puig; Fredrik Karpe; V Krishna K Chatterjee; Stephen O'Rahilly
Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma.
Diabetes 2003;52(4):910-7.
2003: Bettina C Kallenberger; James D Love; V Krishna K Chatterjee; John W R Schwabe
A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease.
Nature structural biology 2003;10(2):136-40.
2003: V Krishna K Chatterjee
Peroxisome proliferator-activated receptor-gamma and insulin action: insights from human genetics.
Hormone research 2003;60 Suppl 3():51-5.
2002: Joanne C Blair; U Mohan; V F Larcher; Odelia Rajanayagam; J M Burrin; LA Perry; Ashley B Grossman; V Krishna K Chatterjee; Martin O Savage
Neonatal thyrotoxicosis and maternal infertility in thyroid hormone resistance due to a mutation in the TRbeta gene (M313T).
Clinical endocrinology 2002;57(3):405-9.
2002: David B Savage; Maura Agostini; Inês Barroso; Mark Gurnell; Jian'an Luan; Aline Meirhaeghe; Anne-Helen Harding; Gudrun Ihrke; Odelia Rajanayagam; Maria A Soos; Stella George; Dirk Berger; E Louise Thomas; Jimmy D Bell; Karim Meeran; R J M Ross; Antonio Vidal-Puig; Nicholas J Wareham; Stephen O'Rahilly; V Krishna K Chatterjee; Alan J Schafer
Digenic inheritance of severe insulin resistance in a human pedigree.
Nature genetics 2002;31(4):379-84.
2002: James D Love; John T Gooch; Szilvia Benko; Chuan Li; Laszlo Nagy; V Krishna K Chatterjee; Ronald M Evans; John W R Schwabe
The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12.
The Journal of biological chemistry 2002;277(13):11385-91.
2002: George J Kahaly; Clare H Matthews; Susanne Mohr-Kahaly; Chris A Richards; V Krishna K Chatterjee
Cardiac involvement in thyroid hormone resistance.
The Journal of clinical endocrinology and metabolism 2002;87(1):204-12.
2001: C Nugent; Johannes B Prins; Jonathan P Whitehead; D Savage; John Wentworth; V Krishna K Chatterjee; Stephen O'Rahilly
Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
Molecular endocrinology (Baltimore, Md.) 2001;15(10):1729-38.
2001: TN Collingwood; FD Urnov; V Krishna K Chatterjee; Alan P Wolffe
Chromatin remodeling by the thyroid hormone receptor in regulation of the thyroid-stimulating hormone alpha-subunit promoter.
The Journal of biological chemistry 2001;276(36):34227-34.
2001: Elli M Gurnell; V Krishna K Chatterjee
Dehydroepiandrosterone replacement therapy.
European journal of endocrinology / European Federation of Endocrine Societies 2001;145(2):103-6.
2001: V Krishna K Chatterjee
Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor gamma resistance.
Biochemical Society transactions 2001;29(Pt 2):227-31.
2001: C Nugent; Johannes B Prins; Jonathan P Whitehead; John Wentworth; V Krishna K Chatterjee; Stephen O'Rahilly
Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma.
The Journal of biological chemistry 2001;276(12):9149-57.
2001: Jian'an Luan; P O Browne; Anne-Helen Harding; Halsall David; Stephen O'Rahilly; V Krishna K Chatterjee; Nicholas J Wareham
Evidence for gene-nutrient interaction at the PPARgamma locus.
Diabetes 2001;50(3):686-9.
2000: Penny J Hunt; Elli M Gurnell; FA Huppert; C Richards; A T Prevost; J A H Wass; Joe Herbert; V Krishna K Chatterjee
Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
The Journal of clinical endocrinology and metabolism 2000;85(12):4650-6.
2000: John Wentworth; Maura Agostini; J Love; John W R Schwabe; V Krishna K Chatterjee
St John's wort, a herbal antidepressant, activates the steroid X receptor.
The Journal of endocrinology 2000;166(3):R11-6.
2000: EO Abu; A Horner; A Teti; V Krishna K Chatterjee; Juliet E Compston
The localization of thyroid hormone receptor mRNAs in human bone.
Thyroid : official journal of the American Thyroid Association 2000;10(4):287-93.
2000: Mark Gurnell; John Wentworth; Maura Agostini; M Adams; TN Collingwood; C Provenzano; P O Browne; Odelia Rajanayagam; Burris thomas; John W R Schwabe; Mitchell Lazar; V Krishna K Chatterjee
A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis.
The Journal of biological chemistry 2000;275(8):5754-9.
2000: John Wentworth; Burris thomas; V Krishna K Chatterjee
HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma/RXR heterodimer.
The Journal of endocrinology 2000;164(2):R7-R10.
2000: James D Love; John T Gooch; Laszlo Nagy; V Krishna K Chatterjee; John W R Schwabe
Transcriptional repression by nuclear receptors: mechanisms and role in disease.
Biochemical Society transactions 2000;28(4):390-6.
1999: Inês Barroso; Mark Gurnell; Vivion E F Crowley; Maura Agostini; John W R Schwabe; Maria A Soos; G L Maslen; T D Williams; H Lewis; Alan J Schafer; V Krishna K Chatterjee; Stephen O'Rahilly
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.
Nature 1999;402(6764):880-3.
1999: Mark Gurnell; Odelia Rajanayagam; Maura Agostini; RJ Clifton-Bligh; T Wang; P M Zelissen; F van der Horst; A van de Wiel; Enrico Macchia; Aldo Pinchera; John W R Schwabe; V Krishna K Chatterjee
Three novel mutations at serine 314 in the thyroid hormone beta receptor differentially impair ligand binding in the syndrome of resistance to thyroid hormone.
Endocrinology 1999;140(12):5901-6.
1999: Alasdair J Coles; Mark G Wing; S Smith; Francesca Coraddu; S Greer; C Taylor; A Weetman; Geoff Hale; V Krishna K Chatterjee; Herman Waldmann; Alastair Compston
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
Lancet 1999;354(9191):1691-5.
1999: John Wentworth; V Schoenfeld; S Meek; greg elgar; Sydney Brenner; V Krishna K Chatterjee
Isolation and characterisation of the retinoic acid receptor-alpha gene in the Japanese pufferfish, F. rubripes.
Gene 1999;236(2):315-23.
1999: Carmela Asteria; Odelia Rajanayagam; TN Collingwood; Luca Persani; Roberto Romoli; Deborah Mannavola; P Zamperini; F Buzi; F Ciralli; V Krishna K Chatterjee; Paolo Beck-Peccoz
Prenatal diagnosis of thyroid hormone resistance.
The Journal of clinical endocrinology and metabolism 1999;84(2):405-10.
1999: Carol Evans; Nils G. Morgenthaler; S Lee; D H Llewellyn; RJ Clifton-Bligh; Rhys John; John H Lazarus; V Krishna K Chatterjee; Marian Ludgate
Development of a luminescent bioassay for thyroid stimulating antibodies.
The Journal of clinical endocrinology and metabolism 1999;84(1):374-7.
1998: TN Collingwood; R Wagner; Clare H Matthews; RJ Clifton-Bligh; Mark Gurnell; Odelia Rajanayagam; Maura Agostini; Robert J Fletterick; Paolo Beck-Peccoz; Walter Reinhardt; G Binder; M B Ranke; A Hermus; R D Hesch; J Lazarus; P Newrick; V Parfitt; P Raggatt; Francis de Zegher; V Krishna K Chatterjee
A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone.
The EMBO journal 1998;17(16):4760-70.
1998: Mark Gurnell; Odelia Rajanayagam; I Barbar; M K Jones; V Krishna K Chatterjee
Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone.
Thyroid : official journal of the American Thyroid Association 1998;8(8):679-82.
1998: RJ Clifton-Bligh; John Wentworth; P Heinz; Michele Crisp; Rhys John; J H Lazarus; Marian Ludgate; V Krishna K Chatterjee
Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia.
Nature genetics 1998;19(4):399-401.
1998: RJ Clifton-Bligh; Francis de Zegher; Richard L Wagner; TN Collingwood; I Francois; Maria van Helvoirt; Robert J Fletterick; V Krishna K Chatterjee
A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation.
Molecular endocrinology (Baltimore, Md.) 1998;12(5):609-21.
1997: M Adams; Montague Carl; Johannes B Prins; J C Holder; S A Smith; L Sanders; JE Digby; Ciaran Sewter; Mitchell Lazar; V Krishna K Chatterjee; Stephen O'Rahilly
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.
The Journal of clinical investigation 1997;100(12):3149-53.
1997: Walter Reinhardt; Friedrich Jockenhövel; J Deuble; V Krishna K Chatterjee; D Reinwein; Klaus Mann
[Thyroid hormone resistance: variable clinical manifestations in five patients].
Nuklearmedizin. Nuclear medicine 1997;36(7):250-5.
1997: Giorgio Radetti; Luca Persani; G Molinaro; Deborah Mannavola; Donatella Cortelazzi; V Krishna K Chatterjee; Paolo Beck-Peccoz
Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance.
Thyroid : official journal of the American Thyroid Association 1997;7(5):775-8.
1997: C Matthews; V Krishna K Chatterjee
Isolated deficiency of follicle-stimulating hormone re-revisited.
The New England journal of medicine 1997;337(9):642.
1997: Luca Persani; D Preziati; Clare H Matthews; Alessandro Sartorio; V Krishna K Chatterjee; Paolo Beck-Peccoz
Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Clinical endocrinology 1997;47(2):207-14.
1997: EO Abu; Sharyn Bord; A Horner; V Krishna K Chatterjee; Juliet E Compston
The expression of thyroid hormone receptors in human bone.
Bone 1997;21(2):137-42.
1997: TN Collingwood; A Butler; Y Tone; RJ Clifton-Bligh; Malcolm G Parker; V Krishna K Chatterjee
Thyroid hormone-mediated enhancement of heterodimer formation between thyroid hormone receptor beta and retinoid X receptor.
The Journal of biological chemistry 1997;272(20):13060-5.
1997: RJ Clifton-Bligh; John W Gregory; Marian Ludgate; Rhys John; Luca Persani; Carmela Asteria; Paolo Beck-Peccoz; V Krishna K Chatterjee
Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH.
The Journal of clinical endocrinology and metabolism 1997;82(4):1094-100.
1997: M Adams; MJ Reginato; D Shao; Mitchell Lazar; V Krishna K Chatterjee
Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site.
The Journal of biological chemistry 1997;272(8):5128-32.
1997: TN Collingwood; Odelia Rajanayagam; M Adams; R Wagner; V Cavaillès; Eric Kalkhoven; C Matthews; E Nystrom; Kaj Stenlöf; G Lindstedt; Lars-Erik Tisell; Robert J Fletterick; Malcolm G Parker; V Krishna K Chatterjee
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(1):248-53.
1997: V Krishna K Chatterjee
Resistance to thyroid hormone.
Hormone research 1997;48 Suppl 4():43-6.
1994: Y Tone; TN Collingwood; M Adams; V Krishna K Chatterjee
Functional analysis of a transactivation domain in the thyroid hormone beta receptor.
The Journal of biological chemistry 1994;269(49):31157-61.
1994: TN Collingwood; M Adams; Y Tone; V Krishna K Chatterjee
Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome.
Molecular endocrinology (Baltimore, Md.) 1994;8(9):1262-77.
1994: Paolo Beck-Peccoz; V Krishna K Chatterjee; W W Chin; L J DeGroot; J Larry Jameson; H Nakamura; S Refetoff; S J Usala; Bruce D Weintraub
Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone: consensus statement from the First Workshop on Thyroid Hormone Resistance, 10-11 July 1993, Cambridge, UK.
Clinical endocrinology 1994;40(5):697-700.
1994: Paolo Beck-Peccoz; V Krishna K Chatterjee; W W Chin; L J DeGroot; J Larry Jameson; H Nakamura; S Refetoff; S J Usala; Bruce D Weintraub
Nomenclature of thyroid hormone receptor-beta gene mutations in resistance to thyroid hormone: consensus statement from the First Workshop on Thyroid Hormone Resistance, 10-11th July 1993, Cambridge, UK.
European journal of endocrinology / European Federation of Endocrine Societies 1994;130(4):426-8.
1994: Paolo Beck-Peccoz; V Krishna K Chatterjee; W W Chin; L J DeGroot; J Larry Jameson; H Nakamura; S Refetoff; S J Usala; Bruce D Weintraub
Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom.
The Journal of clinical endocrinology and metabolism 1994;78(4):990-3.
1994: Paolo Beck-Peccoz; V Krishna K Chatterjee; W W Chin; L J DeGroot; J Larry Jameson; H Nakamura; S Refetoff; S J Usala; Bruce D Weintraub
Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone. First workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, U.K.
Journal of endocrinological investigation 1994;17(4):283-7.
1994: Paolo Beck-Peccoz; V Krishna K Chatterjee; W W Chin; L J DeGroot; J Larry Jameson; H Nakamura; S Refetoff; S J Usala; Bruce D Weintraub
Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11th 1993, Cambridge, U.K.
Thyroid : official journal of the American Thyroid Association 1994;4(1):135-7.
1994: V Krishna K Chatterjee
Resistance to thyroid hormone--an uncommon cause of thyroxine excess and inappropriate TSH secretion.
Acta medica Austriaca 1994;21(2):56-60.
1994: Paolo Beck-Peccoz; V Krishna K Chatterjee
The variable clinical phenotype in thyroid hormone resistance syndrome.
Thyroid : official journal of the American Thyroid Association 1994;4(2):225-32.
1993: C H Matthews; Stefano Borgato; Paolo Beck-Peccoz; M Adams; Y Tone; G Gambino; S Casagrande; G Tedeschini; A Benedetti; V Krishna K Chatterjee
Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone.
Nature genetics 1993;5(1):83-6.
1992: M Adams; T Nagaya; Y Tone; J Larry Jameson; V Krishna K Chatterjee
Functional properties of a novel mutant thyroid hormone receptor in a family with generalized thyroid hormone resistance syndrome.
Clinical endocrinology 1992;36(3):281-9.
1992: V Krishna K Chatterjee; J R Tata
Thyroid hormone receptors and their role in development.
Cancer surveys 1992;14():147-67.
1991: TN Collingwood; M Sydenham; M J Page; V Krishna K Chatterjee
Functional properties of human thyroid hormone receptor beta 1 overexpressed using baculovirus.
FEBS letters 1991;291(2):315-8.